PD · Neurology · 4 drugs · 2 indications
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|---|---|---|---|---|
| Tavapadon | ABBV | D3/D2 partial agonist | Small molecule | PO | FILED |
| Prasinezumab | ROG.SW | Alpha-synuclein targeting | Antibody | IV | PHASE3 |
| Glovadalen | UCB | Dopamine D1 receptor PAM | Small molecule | Oral | PHASE2 |
| Neupro | UCB | Dopamine agonist | Small molecule | Transdermal | APPROVED |